Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peggy Riese

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Microbial Biotechnology|August 16, 2017
Roads to advanced vaccines: influenza case studyPeggy Riese, Carlos A Guzmán
Expert Opinion on Drug Delivery|June 26, 2014
Intranasal formulations: promising strategy to deliver vaccinesPeggy Riese, Priya Sakthivel, Stephanie Trittel, et al.
Expert Review of Vaccines|August 14, 2015
Rodents as pre-clinical models for predicting vaccine performance in humansPeggy Riese, Stephanie Trittel, Kai Schulze, et al.
Clinical and Vaccine Immunology : CVI|June 15, 2007
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvantThomas Ebensen, Kai Schulze, Peggy Riese, et al.
Current Topics in Medicinal Chemistry|September 27, 2013
Vaccine adjuvants: key tools for innovative vaccine designPeggy Riese, Kai Schulze, Thomas Ebensen, et al.
Scientific Reports|November 10, 2019
Key features and homing properties of NK cells in the liver are shaped by activated iNKT cellsStephanie Trittel, Benedict J Chambers, Ulrike Heise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
A pegylated derivative of alpha-galactosylceramide exhibits improved biological propertiesThomas Ebensen, Claudia Link, Peggy Riese, et al.
Vaccine|December 26, 2006
The bacterial second messenger cyclic diGMP exhibits potent adjuvant propertiesThomas Ebensen, Kai Schulze, Peggy Riese, et al.
Frontiers in Immunology|April 7, 2018
Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR ExpressionNeha Vashist, Stephanie Trittel, Thomas Ebensen, et al.
Frontiers in Immunology|August 24, 2019
Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune InterventionStephanie Trittel, Neha Vashist, Thomas Ebensen, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Microbial Biotechnology|August 16, 2017
Roads to advanced vaccines: influenza case studyPeggy Riese, Carlos A Guzmán
Expert Opinion on Drug Delivery|June 26, 2014
Intranasal formulations: promising strategy to deliver vaccinesPeggy Riese, Priya Sakthivel, Stephanie Trittel, et al.
Expert Review of Vaccines|August 14, 2015
Rodents as pre-clinical models for predicting vaccine performance in humansPeggy Riese, Stephanie Trittel, Kai Schulze, et al.
Clinical and Vaccine Immunology : CVI|June 15, 2007
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvantThomas Ebensen, Kai Schulze, Peggy Riese, et al.
Current Topics in Medicinal Chemistry|September 27, 2013
Vaccine adjuvants: key tools for innovative vaccine designPeggy Riese, Kai Schulze, Thomas Ebensen, et al.
Scientific Reports|November 10, 2019
Key features and homing properties of NK cells in the liver are shaped by activated iNKT cellsStephanie Trittel, Benedict J Chambers, Ulrike Heise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
A pegylated derivative of alpha-galactosylceramide exhibits improved biological propertiesThomas Ebensen, Claudia Link, Peggy Riese, et al.
Vaccine|December 26, 2006
The bacterial second messenger cyclic diGMP exhibits potent adjuvant propertiesThomas Ebensen, Kai Schulze, Peggy Riese, et al.
Frontiers in Immunology|April 7, 2018
Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR ExpressionNeha Vashist, Stephanie Trittel, Thomas Ebensen, et al.
Frontiers in Immunology|August 24, 2019
Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune InterventionStephanie Trittel, Neha Vashist, Thomas Ebensen, et al.
Pageof 6